Relx (NYSE:RELX) Hits New 12-Month High – Should You Buy?

Relx Plc (NYSE:RELX)’s stock price hit a new 52-week high during trading on Wednesday . The stock traded as high as $50.56 and last traded at $50.56, with a volume of 130415 shares traded. The stock had previously closed at $49.86.

Analyst Ratings Changes

Several analysts have recently issued reports on the company. Redburn Atlantic started coverage on Relx in a research report on Wednesday, January 8th. They issued a “buy” rating on the stock. StockNews.com assumed coverage on Relx in a research report on Wednesday, October 30th. They set a “hold” rating on the stock.

Relx Price Performance

The company has a current ratio of 0.48, a quick ratio of 0.42 and a debt-to-equity ratio of 1.63. The firm’s 50 day simple moving average is $47.25 and its two-hundred day simple moving average is $46.89.

Hedge Funds Weigh In On Relx

Several hedge funds and other institutional investors have recently modified their holdings of RELX. CENTRAL TRUST Co boosted its holdings in shares of Relx by 1,290.2% during the fourth quarter. CENTRAL TRUST Co now owns 570 shares of the technology company’s stock valued at $26,000 after acquiring an additional 529 shares during the period. Versant Capital Management Inc acquired a new position in shares of Relx during the fourth quarter valued at $31,000. Sierra Ocean LLC acquired a new position in shares of Relx during the fourth quarter valued at $43,000. Private Trust Co. NA boosted its holdings in shares of Relx by 119.9% during the third quarter. Private Trust Co. NA now owns 1,038 shares of the technology company’s stock valued at $49,000 after acquiring an additional 566 shares during the period. Finally, Whipplewood Advisors LLC acquired a new stake in Relx in the fourth quarter worth about $74,000. Institutional investors and hedge funds own 15.02% of the company’s stock.

About Relx

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.